Junshi Biosciences and Coherus Announce Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Clinical Trial Evaluating Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma

– Final overall survival analysis of the JUPITER-02 trial shows first-line treatment with toripalimab plus chemotherapy significantly prolongs survival in patients with advanced NPC – SHANGHAI, China and REDWOOD CITY, Calif., Feb. 15, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”) today announced […]

Read More

GreySkies Service Assurance Software Platform Helps Orange Egypt Reduce Operational Costs

GreySkies provides end-to-end visibility for Orange Egypt’s fixed and mobile networks Featured Image for Greyskies Inc. SEATTLE, Feb. 15, 2023 (GLOBE NEWSWIRE) — Today GreySkies, a telecommunications service assurance software provider, announced the completion of the deployment of its market-leading platform at Orange Egypt, the world’s leading telecommunications operator, enabling the reduction of their service […]

Read More

100 Days to Go Until Vivid Sydney Dazzles Again

Vivid Sydney SYDNEY, Feb. 15, 2023 (GLOBE NEWSWIRE) — The countdown to Vivid Sydney 2023 has officially begun, with today marking 100 days until the festival’s Lights On moment at 6 p.m. on Friday, 26 May (AEST). Celebrating creativity, innovation and technology, Australia’s largest festival will dazzle and delight audiences for 23 days and nights […]

Read More